Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected turkish women: a large screening study
- PMID: 37055708
- DOI: 10.1007/s40618-023-02093-5
Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected turkish women: a large screening study
Abstract
Purpose: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders resulting from enzyme deficiencies associated with steroidogenesis. The clinical presentation of non-classic CAH (NCAH) in females is often indistinguishable from other hyperandrogenic disorders like polycystic ovary syndrome (PCOS). The data on the prevalence of NCAH in unselected women in the literature is scanty. The research aimed to evaluate the prevalence of NCAH, carrier frequencies, and the correlation between clinical symptoms and genotype in Turkish women.
Methods: The study group comprised two hundred and seventy randomly-selected unrelated asymptomatic women of reproductive age (18-45). Subjects were recruited from female blood donors. All volunteers underwent clinical examination and hormone measurements. The protein-encoding exons and exon-intron boundaries of the CYP21A2, CYP11B1, HSD3β2 and CYP21A2 promoter were sequenced by direct DNA sequencing.
Results: After genotyping, seven (2.2%) individuals were diagnosed with NCAH. The heterozygous carrier frequencies of CYP21A2, CYP21A2 promoter, CYP11B1, and HSD3β2 genes with 34, 34, 41, and 1 pathologic mutation were determined at 12.6%, 12.6%, 15.2%, and 0.37% of volunteers, respectively. Gene-conversion (GC) frequencies between CYP21A2/CYP21A1P and CYP11B1/CYP11B2 were determined as 10.4% and 14.8%, respectively.
Conclusion: Despite GC-derived higher mutation frequency determined in the CYP11B1 gene, the reason for the low frequency of NCAH due to 11OHD compared to 21OHD might be that gene-conversion arises with active CYP11B2 rather than an inactive pseudogene. HSD3β1 exhibits high homology with HSD3β2 located on the same chromosome; remarkably, it demonstrates low heterozygosity and no GC, most probably the outcome of a tissue-specific expression pattern.
Keywords: CYP11B1; CYP21A2; Comprehensive genotyping; HSD3β2; Randomly-selected women.
© 2023. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
Similar articles
-
Comprehensive genotyping of Turkish women with hirsutism.J Endocrinol Invest. 2019 Sep;42(9):1077-1087. doi: 10.1007/s40618-019-01028-3. Epub 2019 Feb 27. J Endocrinol Invest. 2019. PMID: 30811025
-
Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation.Hormones (Athens). 2016 Apr;15(2):235-242. doi: 10.14310/horm.2002.1651. Hormones (Athens). 2016. PMID: 27376426
-
Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.J Steroid Biochem Mol Biol. 2021 Jul;211:105899. doi: 10.1016/j.jsbmb.2021.105899. Epub 2021 Apr 14. J Steroid Biochem Mol Biol. 2021. PMID: 33864926
-
Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants.Hormones (Athens). 2022 Mar;21(1):155-161. doi: 10.1007/s42000-021-00322-1. Epub 2021 Oct 26. Hormones (Athens). 2022. PMID: 34697763 Review.
-
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis.Mol Diagn Ther. 2024 Mar;28(2):215-224. doi: 10.1007/s40291-024-00697-y. Epub 2024 Feb 7. Mol Diagn Ther. 2024. PMID: 38324138 Review.
References
-
- Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776–788. https://doi.org/10.1056/NEJMra021561 - DOI - PubMed
-
- New MI (2001) Prenatal treatment of congenital adrenal hyperplasia: the United States experience. Endocrinol Metab Clin N Am 30:1–13 - DOI
-
- Miller WL, Auchus RJ (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 32:81–151. https://doi.org/10.1210/er.2010-0013 - DOI - PubMed
-
- Kelestimur F (2006) Non-classic congenital adrenal hyperplasia. Pediatr Endocrinol Rev 3:451–454 - PubMed
-
- Polat S, Kulle A, Karaca Z, Akkurt I, Kurtoglu S, Kelestimur F, Grötzinger J, Holterhus PM, Riepe FG (2014) Characterisation of three novel CYP11B1 mutations in classic and non-classic 11beta-hydroxylase deficiency. Eur J Endocrinol 170:697–706. https://doi.org/10.1530/EJE-13-0737 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous